Latest 10-K annual reports

NASDAQ
Interactive Strength Inc. files an amendment to its annual report to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and accounting fees.
NASDAQ
Plug Power files an amendment to its 2024 Annual Report on Form 10-K to include Part III information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.
NASDAQ
SBC Medical Group Holdings files an amendment to its 2024 annual report to include previously omitted information on directors, executive compensation, and corporate governance, while also updating details on a new executive employment agreement.
Luminar Technologies files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, accounting fees, and executive certifications.
Lazydays Holdings files an amendment to its 2024 annual report, restating financial statements due to a warrant liability error and addressing concerns about its ability to continue as a going concern.
NASDAQ
TransCode Therapeutics files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, and corporate governance.
NASDAQ
SUNation Energy submitted an amended annual report primarily to incorporate details on its directors, executive officers, compensation structures, and corporate governance following recent leadership transitions and financial activities.
NASDAQ
Broadway Financial Corporation files an amendment to its annual report on Form 10-K to include information required by Part III, as the proxy statement for the 2025 Annual Meeting of Stockholders will not be filed within 120 days after the end of the company's 2024 fiscal year.
NASDAQ
Workhorse Group Inc. files an amendment to its 2024 Annual Report on Form 10-K to include Part III information due to an expected delay in filing its 2025 Definitive Proxy Statement.
NASDAQ
Greenwave Technology Solutions files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, and updated certifications.
Thumzup Media Corporation files an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, and corporate governance.
Sunnova Energy International Inc. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, compensation, and corporate governance.
NASDAQ
Dolphin Entertainment files an amendment to its annual report on Form 10-K to include information required by Items 10 through 14 of Part III.
NASDAQ
Arcadia Biosciences files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.
NASDAQ
Ovid Therapeutics files an amendment to its annual report to include information required by Items 10 through 14 of Part III, related to directors, executive officers, compensation, and corporate governance.
NASDAQ
Rocket Lab has filed an amendment to its 2024 Annual Report on Form 10-K to include information regarding directors, executive officers, corporate governance, and executive compensation.
NASDAQ
Tempest Therapeutics files an amendment to its annual report on Form 10-K to include required information on directors, executive officers, corporate governance, and updated certifications.
NASDAQ
LENSAR, Inc. files an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.
NYSE
SES AI Corporation filed an amendment to its 2024 annual report to include information on directors, executive officers, and their compensation.
NASDAQ
Plus Therapeutics files an amendment to its 2024 Annual Report on Form 10-K to include information previously omitted from Part III, Items 10 through 14, and updates the exhibit list and share outstanding information.
AMEX
Volato Group, Inc. files an amendment to its 2024 Annual Report on Form 10-K to include information required by Part III, which was previously omitted.
NASDAQ
BankFinancial Corporation files an amendment to its 2024 annual report on Form 10-K to include information required in Part III, focusing on directors, executive officers, and corporate governance.
Volcon, Inc. files an amendment to its 2024 annual report to include certain interactive data file tagging and certifications by the principal executive and financial officers.
NASDAQ
Expion360 Inc. files an amendment to its 2024 Annual Report on Form 10-K/A to include Part III information regarding directors, executive officers, and corporate governance.
OTC.Pink
Scorpius Holdings grapples with NYSE American delisting, significant losses, and a search for strategic options as it navigates a challenging financial landscape.
NASDAQ
UroGen Pharma files an amendment to its 2024 annual report to include information required by Part III of Form 10-K, covering directors, executive officers, compensation, security ownership, related transactions, and accountant fees.
AMEX
i-80 Gold Corp. files an amendment to its 2024 annual report to include Part III information regarding directors, executive officers, and corporate governance.
OTC.Pink
Four Leaf Acquisition Corporation's annual report reveals a company grappling with financial uncertainties, Nasdaq delisting notices, and ongoing efforts to finalize a business combination with Xiaoyu Dida.
OTC.Pink
American Rebel Holdings files an amendment to its 2024 Annual Report on Form 10-K to include an inadvertently omitted exhibit regarding executive compensation recovery policy.
NASDAQ
BGC Group files an amendment to its 2024 annual report, providing additional information on directors, executive compensation, corporate governance, and related matters.